Dapagliflozin: New HF Therapy, Even Sans Diabetes Dapagliflozin: New HF Therapy, Even Sans Diabetes

Significant reductions in heart failure events and mortality associated with the diabetes drug in the randomized trial point to a new era in the treatment of heart failure, experts say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news